The classification of TRM as a separate subset of CD8 T cell memory prompted new investigations to define the factors that contribute to TRM development and maintenance, how TRM-mediated immunity contributes to the dynamic immune response to microbial pathogens, and if TRM function can be harnessed for a multimodal therapeutic approach to treat or prevent infection and cancer. This evidence concerns the gene CD8A and infection.